Evolus (EOLS) Cash & Equivalents Growth (1y) (2019 - 2026)
Evolus (EOLS) Cash & Equivalents Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 120.45% |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 12.78% |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | -32.64% |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | -57.43% |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 37.30% |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | -12.11% |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -12.07% |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | -46.88% |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | -18.80% |
| 10 | Evolus | 439.03 Mn | 389.24 Mn | 48.90 Mn | -26.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.66% |
| Dec 31, 2025 | -38.10% |
| Sep 30, 2025 | -48.82% |
| Jun 30, 2025 | -34.09% |
| Mar 31, 2025 | -29.98% |
| Dec 31, 2024 | 38.37% |
| Sep 30, 2024 | 119.81% |
| Jun 30, 2024 | 124.60% |
| Mar 31, 2024 | 208.17% |
| Dec 31, 2023 | 16.53% |
| Sep 30, 2023 | -41.00% |
| Jun 30, 2023 | -50.64% |
| Mar 31, 2023 | -70.50% |
| Dec 31, 2022 | -63.13% |
| Sep 30, 2022 | -39.17% |
| Jun 30, 2022 | -35.87% |
| Mar 31, 2022 | 381.13% |
| Dec 31, 2021 | 42.60% |
| Sep 30, 2021 | 26.63% |
| Jun 30, 2021 | 342.49% |